![Image treatment Image treatment](https://research.euro.savills.co.uk/_images/phillynewskylineimage(5).jpg)
Market Highlights
- Poland based SDS Optic announced they will open its new U.S. lab operations at BioLabs Philadelphia.
- Synnovation Therapeutics, a company focused on creating targeted small molecule therapies, raised $102.0 million in Series A funding which will be used to fund the clinical and preclinical pipeline.
- The Keystone LifeSci Collaborative, a new initiative formed by local life sciences leaders and community partners, aims to establish a platform for industry executives to strengthen Philadelphia's appeal as a premier life sciences hub.